可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:
[1] Pan XR, Li GW , Hu YH, et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose to lerance[J]. Diabetes Care, 1997, 20: 537- 544.
[2] Antonucci T,Whitcomb R,Mclian R, et al. Impaired glucose tolerance is normalized by treatment with the thiazo lidinedione troglitazone[J]. Diabetes Care, 1997, 20: 188- 193.
[3] 李光伟, 潘孝仁. 空腹血胰岛素、葡萄糖比值作为B细胞功能指数的可能性[J]. 中华内分泌代谢杂志, 1998, 8: 232.
[4] 李光伟, 潘孝仁,Lillioja S, 等. 检测人群胰岛素敏感性的一项新指数[J]. 中华内科杂志, 1993, 33: 656.
[5] Stenven A G, Cynthia SP, Louis C. Serum lipid screening to identify high-risk individuals for coronary death: The results of the lipid research clinics prevalence cohort [J]. Arch Intern Med , 1994, 154: 679.
[6] Capes SE, Hunt D,Malmberg K, et al. Stress hyperglycemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview [J].Lancet, 2000, 355: 773- 778.
[7] Haffner SM. Impaired glucose tolerance, insulin resistance and cardiovascular disease [J]. Diabetic Med , 1997, 14 ( supp l 3) :s12.
[8] Stenven A G, Louis C, Hu XP. Identifying adults at increased risk of coronary disease[J]. JAMA , 1995, 274: 801.
[9] Illingworth DR. Coronary heart disease of new lyetiological factor[J]. Am J Med , 1999, 107 (2A ) : 195- 215.